(Q41943814)

14 October 2017

Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics (English)

1 reference

14 October 2017

2

1 reference

14 October 2017

Pedro J Gonzalez-Cabrera

series ordinal

1

1 reference

PubMed ID

17218309

14 October 2017

Hugh Rosen

series ordinal

3

1 reference

PubMed ID

17218309

14 October 2017

language of work or name

English

0 references

publication date

10 January 2007

1 reference

Journal of Biological Chemistry

14 October 2017

1 reference

14 October 2017

282

1 reference

14 October 2017

7254-7264

1 reference

14 October 2017

10

1 reference

Novel roles for arrestins in the post-endocytic trafficking of G protein-coupled receptors

14 October 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Regulated ubiquitination of proteins in GPCR-initiated signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Rapid induction of medullary thymocyte phenotypic maturation and egress inhibition by nanomolar sphingosine 1-phosphate receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Ubiquitin and endocytic protein sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M610581200

21 January 2018

Identifiers

DOI

10.1074/JBC.M610581200

1 reference

14 October 2017

1 reference

PubMed ID

17218309